Skip to main content
. 2013 Dec;347(3):755–764. doi: 10.1124/jpet.113.208959

Fig. 1.

Fig. 1.

(A) Plasma concentration-time profiles of sunitinib after a single oral dose (20 mg/kg) in FVB wild-type, Mdr1a/b(−/−), Bcrp1(−/−), and Mdr1a/b(−/−)Bcrp1(−/−) mice. (B) Corresponding brain concentration-time profiles of sunitinib after a single oral dose (20 mg/kg) in FVB wild-type, Mdr1a/b(−/−), Bcrp1(−/−), and Mdr1a/b(−/−)Bcrp1(−/−) mice. (C) Brain-to-plasma ratios with time in wild-type, Mdr1a/b(−/−), Bcrp1(−/−), and Mdr1a/b(−/−)Bcrp1(−/−) mice.